Phase
Condition
Metastatic Cancer
Breast Cancer
Treatment
Biopsy
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patient over 18 years of age
Advanced breast cancer
Triple-negative phenotype (HR-/HER2-) or HR+/HER2- after hormone resistance (progression after treatment with hormone therapy + CDK4/6 inhibitor)
Tumor measurable according to RECISTv1.1 criteria, accessible to biopsy
Performans Status 0-1
Exclusion
Exclusion Criteria:
More than 3 lines of chemotherapy in the advanced setting (excluding hormonetherapy/CDK4/6 inhibitor)
Progressive brain metastases
Leptomeningeal metastasis
Study Design
Study Description
Connect with a study center
Hôpital Saint-Louis - AP-HP Senopole
Paris, 75010
FranceSite Not Available
Institut Curie
Paris, 75005
FranceActive - Recruiting
Institut Curie
Saint-Cloud, 92210
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.